Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.

Channeling occurs when a medication and its potential comparators are selectively prescribed based on differences in underlying patient characteristics. Drug safety advisories can provide new information regarding the relative safety or effectiveness of a drug product which might increase selective...

Full description

Bibliographic Details
Main Authors: Stacie B Dusetzina, Christina D Mack, Til Stürmer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3646952?pdf=render
id doaj-2ed26ff3ff62428688c5b2b706f636fb
record_format Article
spelling doaj-2ed26ff3ff62428688c5b2b706f636fb2020-11-24T22:06:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6397310.1371/journal.pone.0063973Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.Stacie B DusetzinaChristina D MackTil StürmerChanneling occurs when a medication and its potential comparators are selectively prescribed based on differences in underlying patient characteristics. Drug safety advisories can provide new information regarding the relative safety or effectiveness of a drug product which might increase selective prescribing. In particular, when reported adverse effects vary among drugs within a therapeutic class, clinicians may channel patients toward or away from a drug based on the patient's underlying risk for an adverse outcome. If channeling is not identified and appropriately managed it might lead to confounding in observational comparative effectiveness studies.To demonstrate channeling among new users of second generation antipsychotics following a Food and Drug Administration safety advisory and to evaluate the impact of channeling on cardiovascular risk estimates over time.Florida Medicaid data from 2001-2006.Retrospective cohort of adults initiating second generation antipsychotics. We used propensity scores to match olanzapine initiators with other second generation antipsychotic initiators. To evaluate channeling away from olanzapine following an FDA safety advisory, we estimated calendar time-specific propensity scores. We compare the performance of these calendar time-specific propensity scores with conventionally-estimated propensity scores on estimates of cardiovascular risk.Increased channeling away from olanzapine was evident for some, but not all, cardiovascular risk factors and corresponded with the timing of the FDA advisory. Covariate balance was optimized within period and across all periods when using the calendar time-specific propensity score. Hazard ratio estimates for cardiovascular outcomes did not differ across models (Conventional PS: 0.97, 95%CI: 0.81-3.18 versus calendar time-specific PS: 0.93, 95%CI: 0.77-3.04).Changes in channeling over time was evident for several covariates but had limited impact on cardiovascular risk estimates, possibly due to unmeasured confounding. Although calendar time-specific propensity scores appear to improve covariate balance, the impact on comparative effectiveness results is limited in this setting.http://europepmc.org/articles/PMC3646952?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Stacie B Dusetzina
Christina D Mack
Til Stürmer
spellingShingle Stacie B Dusetzina
Christina D Mack
Til Stürmer
Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
PLoS ONE
author_facet Stacie B Dusetzina
Christina D Mack
Til Stürmer
author_sort Stacie B Dusetzina
title Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
title_short Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
title_full Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
title_fullStr Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
title_full_unstemmed Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
title_sort propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Channeling occurs when a medication and its potential comparators are selectively prescribed based on differences in underlying patient characteristics. Drug safety advisories can provide new information regarding the relative safety or effectiveness of a drug product which might increase selective prescribing. In particular, when reported adverse effects vary among drugs within a therapeutic class, clinicians may channel patients toward or away from a drug based on the patient's underlying risk for an adverse outcome. If channeling is not identified and appropriately managed it might lead to confounding in observational comparative effectiveness studies.To demonstrate channeling among new users of second generation antipsychotics following a Food and Drug Administration safety advisory and to evaluate the impact of channeling on cardiovascular risk estimates over time.Florida Medicaid data from 2001-2006.Retrospective cohort of adults initiating second generation antipsychotics. We used propensity scores to match olanzapine initiators with other second generation antipsychotic initiators. To evaluate channeling away from olanzapine following an FDA safety advisory, we estimated calendar time-specific propensity scores. We compare the performance of these calendar time-specific propensity scores with conventionally-estimated propensity scores on estimates of cardiovascular risk.Increased channeling away from olanzapine was evident for some, but not all, cardiovascular risk factors and corresponded with the timing of the FDA advisory. Covariate balance was optimized within period and across all periods when using the calendar time-specific propensity score. Hazard ratio estimates for cardiovascular outcomes did not differ across models (Conventional PS: 0.97, 95%CI: 0.81-3.18 versus calendar time-specific PS: 0.93, 95%CI: 0.77-3.04).Changes in channeling over time was evident for several covariates but had limited impact on cardiovascular risk estimates, possibly due to unmeasured confounding. Although calendar time-specific propensity scores appear to improve covariate balance, the impact on comparative effectiveness results is limited in this setting.
url http://europepmc.org/articles/PMC3646952?pdf=render
work_keys_str_mv AT staciebdusetzina propensityscoreestimationtoaddresscalendartimespecificchannelingincomparativeeffectivenessresearchofsecondgenerationantipsychotics
AT christinadmack propensityscoreestimationtoaddresscalendartimespecificchannelingincomparativeeffectivenessresearchofsecondgenerationantipsychotics
AT tilsturmer propensityscoreestimationtoaddresscalendartimespecificchannelingincomparativeeffectivenessresearchofsecondgenerationantipsychotics
_version_ 1725821501155835904